canSAR: update to the cancer translational research and drug discovery knowledgebase.
Nucleic Acids Res
; 51(D1): D1212-D1219, 2023 01 06.
Article
en En
| MEDLINE
| ID: mdl-36624665
ABSTRACT
canSAR (https//cansar.ai) is the largest public cancer drug discovery and translational research knowledgebase. Now hosted in its new home at MD Anderson Cancer Center, canSAR integrates billions of experimental measurements from across molecular profiling, pharmacology, chemistry, structural and systems biology. Moreover, canSAR applies a unique suite of machine learning algorithms designed to inform drug discovery. Here, we describe the latest updates to the knowledgebase, including a focus on significant novel data. These include canSAR's ligandability assessment of AlphaFold; mapping of fragment-based screening data; and new chemical bioactivity data for novel targets. We also describe enhancements to the data and interface.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Bases del Conocimiento
/
Descubrimiento de Drogas
/
Investigación Biomédica Traslacional
/
Antineoplásicos
Límite:
Humans
Idioma:
En
Revista:
Nucleic Acids Res
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos